This occurs when TGF-β newly secreted by the cancer cells activates a TGF-β receptor 1 (TGF-βRI) RAC1/SMAD-mediated signaling pathway in the mesothelial cells that upregulates mesothelial cell fibronectin secretion. This evidence concerns the gene FN1 and cancer.